Olaparib - Wikipedia
令癌莎- Wikiwand
PARP inhibitor - Wikipedia
Olaparib - Wikipedia, la enciclopedia libre
PharmaWiki - Olaparib
HemOnc.org | A Hematology Oncology Wiki
Olaparib | AZD-2281 | CAS#763113-22-0 | MedKoo
Olaparib - Wikipedia
Tankyrase inhibitors as antitumor agents: a patent update (2013 – 2020)
Cancers | Free Full-Text | Candidate Markers of Olaparib Response from Genomic Data Analyses of Human Cancer Cell Lines
Olaparib – Wikipedia
Two Cocrystals of Olaparib with Flavonoids toward Sustained Release: Structure, Dissolution Behavior, and Anticancer Activity Analysis | Crystal Growth & Design
TGFβR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow Microenvironment - ScienceDirect
Targeting dePARylation selectively suppresses DNA repair–defective and PARP inhibitor–resistant malignancies | Science Advances
Two Cocrystals of Olaparib with Flavonoids toward Sustained Release: Structure, Dissolution Behavior, and Anticancer Activity Analysis | Crystal Growth & Design
olaparib | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY
HemOnc.org | A Hematology Oncology Wiki
Cancers | Free Full-Text | Candidate Markers of Olaparib Response from Genomic Data Analyses of Human Cancer Cell Lines
Integrated proteomics identifies PARP inhibitor-induced prosurvival signaling changes as potential vulnerabilities in ovarian ca
Olaparib CAS 763113-22-0 Watson International Limited
Olaparib | C24H23FN4O3 | ChemSpider
令癌莎- Wikiwand
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. - Abstract - Europe PMC
Olaparib: Cos'è, A Cosa Serve, Quando si Assume
